Cedeño, Baby Girl .

HRN: 27-27-33  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/21/2025
06/28/2025
IV
38mg
OD
PNSB
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: